CIOMS WG XIII: Real-World Data and Real-World Evidence in Regulatory Decision Making
Please, see the report by "CIOMS WG XIII: Real-World Data and Real-World Evidence in Regulatory Decision Making". Juhaeri JUHAERI, Ph.D., Head, Epidemiology and Benefit-Risk Evaluation, Sanofi.
On September 16, 2021, the Association of Health Technology Assessment Professionals, the Association of Clinical Pharmacologists, the St. Petersburg Chapter of the International Society for Pharmacoeconomic and Outcomes Research (ISPOR) organized and held the II annual scientific and practical conference with international participation “RWD/RWE – Research Tools of Real-World Clinical Practice Today and Tomorrow”.
There were 30 reports presented at the conference.
Please, see the report by "CIOMS WG XIII: Real-World Data and Real-World Evidence in Regulatory Decision Making". Juhaeri JUHAERI, Ph.D., Head, Epidemiology and Benefit-Risk Evaluation, Sanofi.
The web-site of this journal uses cookies to optimize its performance and design as well as special service to collect and analyze data about pages visitors. By continuing to browse this web-site you agree to use cookies and the above service.